Comments
Loading...
Amedisys (NASDAQ:AMED) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Amedisys (AMED)?
The most recent guidance for Amedisys (AMED) was reported on May 3, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $4.14 to $4.36, compared to the estimated EPS of $4.25. Additionally, Amedisys forecasted revenue between $2.25B and $2.27B for the quarter.
Browse guidance and forecast on all stocks.